{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T03:36:51.707486",
  "document": "Alpha-Thalassemia-X.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Alpha-Thalassemia-X.pdf",
  "total_candidates": 8,
  "total_validated": 1,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "heuristics_counters": {
    "recovered_by_stats_whitelist": 0,
    "recovered_by_country_code": 0,
    "recovered_by_hyphen": 0,
    "recovered_by_direct_search": 0,
    "recovered_by_llm_sf_only": 1,
    "blacklisted_fp_count": 0,
    "common_word_rejected": 0,
    "context_rejected": 0,
    "form_filter_rejected": 0,
    "trial_id_excluded": 0
  },
  "abbreviations": [
    {
      "short_form": "ATR-X",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "ATR-X syndrome affects males. More than 200 cases have been reported to laboratories conducting molecular",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    }
  ],
  "diseases": [
    {
      "name": "ATR-X syndrome",
      "matched_text": "ATR-X syndrome",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": "ICD10CM:D56.0",
      "orpha": "Orphanet:847"
    }
  ],
  "drugs": [],
  "pharma": []
}